March 8, 2024
SAN DIEGO — In the clinical experience of Mio Nakamura, MD, MS, providing dermatologic care to patients with personality disorders requires a certain level of flexibility […]
March 8, 2024
A once-daily oral combination therapy for HIV — bictegravir plus lenacapavir — is more effective than complex regimens are, according to results from a phase 2 […]
March 8, 2024
The REMS Public Dashboard is an interactive web-based tool that will allow for the analysis of REMS data in a user-friendly way. The intention of this […]
March 8, 2024
Login, complete evaluation, and print certificate Navigate to https://ceportal.fda.gov/ If you have an account, please login If you do not have an account, click on “Create […]
March 8, 2024
Login, complete evaluation, and print certificate Navigate to https://ceportal.fda.gov/ If you have an account, please login If you do not have an account, click on “Create […]
March 8, 2024
The US Food and Drug Administration (FDA) has approved the anti-obesity drug semaglutide 2.4 mg injection (Wegovy) for reducing cardiovascular risk in adults with overweight or […]
March 8, 2024
A resolution to eliminate diversity efforts at the American Academy of Dermatology (AAD) has sparked fierce controversy on the eve of the group’s annual conference in […]
March 8, 2024
90 208237 Memantine and Donepezil Hydrochloride Extended-Release Capsules, 21 mg/10 mg and 28 mg/10 mg ANI Pharmaceuticals, Inc. Namzaric (Memantine and Donepezil Hydrochloride) Extended-Release Capsules 12/15/2023 […]
March 8, 2024
For Immediate Release: March 08, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623
Next page